Back to Trades
de Verneuil Vanina
EVPGeneral CounselCorp SecCIK 0002036234
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2025–2026
de Verneuil Vanina, EVP, General Counsel, Corp Sec, has filed 3 SEC reports (2025–2026), all concentrated in Vir Biotechnology, Inc. (VIR), totaling $885.0K in disclosed volume. Weighing $0 bought versus $53.4K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Feb 24 | VIR Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell | $33.1K |
| Nov 7 | VIR Vir Biotechnology, Inc. | de Verneuil Vanina | EVP, General Counsel, Corp Sec | Sell | $12.3K |
| Nov 4 | VIR Vir Biotechnology, Inc. | de Verneuil Vanina | EVP and General Counsel | Sell | $8.0K |
3 filings